Market Overview

Revance Therapeutics (NASDAQ: RVNC)

28.08 -0.51 (-1.78%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2021
After-Hours
EPS:
REV:
-1.34
3.835M



Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-1.15
58K



Q4 2020
After-Hours
EPS:
REV:
-0.99
89K



Q3 2020
After-Hours
EPS:
REV:
-0.96
46K
-1.03
1.78M
-1.34
3.835M
-30.1%
115.45%
Q2 2020
After-Hours
EPS:
REV:
-0.86
0
-1.01
450K
-1.12
299K
-10.89%
-33.56%
Q1 2020
After-Hours
EPS:
REV:
-0.85
278K
-0.90
170K
-1.15
58K
-27.78%
-65.88%
Q4 2019
After-Hours
EPS:
REV:
-1.12
487K
-0.98
2.29M
-0.99
89K
-1.02%
-96.11%
Q3 2019
After-Hours
EPS:
REV:
-0.91
2.362M
-0.98
430K
-0.96
46K
2.04%
-89.3%
Q2 2019
After-Hours
EPS:
REV:
-0.94
686K
-0.91
710K
-0.86
0
5.49%
-100%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!